Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Synagis 50mg°°


Contraindicated
No indication during pregnancy

Contraindicated
No indication in breastfeeding women
Synagis 50mg°° :
Type Medicine Withdrawn
Originator Biotech (Synagis 50mg)
Agent Omnipharma
Distributor Omnipharma
Laboratory AbbVie
Responsible Party Abbvie Ltd
Origin UK
Manufacturer Boehringer Ingelheim Pharma GmbH & Co KG
Origin Germany
ATC J06BB16

Your comment will appear shortly after approval

Synagis 50mg°° :

Revision Date : 22/08/2014


Effect Frequency
Anaphylactic reactions Not known
Anaphylactic shock Not known
Apnoea (Apnea) Common
Injection site reaction Common
Pyrexia Very Common
Seizures Uncommon
Skin rash Very Common
Thrombocytopenia (Thrombopenia) Uncommon
Urticaria Uncommon

Different Units By MoH Code

Revision Date : 01/11/2013

Synagis 50mg°°  MoH 9302 :
Form Solution for injection
Packaging Bottle
Package Size 1 x0.5ml
Strength 50mg
Storage Condition 2-8°C Do not freeze
NSSF ✘
Quarantine ✔
Reg. Number 129217/1
Submission date 01/01/2018
Registration Year 2018
Withdrawn Date 04/09/2024

Price Comparison

Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info